Gloperba side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Gloperba. Common side effects include abdominal pain among females and acute hepatic failure among males.

The phase IV clinical study is created by eHealthMe based on 32 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jun, 10, 2023

32 people who take Gloperba and have side effects are studied.


What is Gloperba?

Gloperba has active ingredients of colchicine. eHealthMe is studying from 32 Gloperba users for its effectiveness, alternative drugs and more.

Number of Gloperba reports submitted per year:

Gloperba side effects.

Gloperba side effects by gender *:

female:

  1. Abdominal pain
  2. Abdominal discomfort
  3. Abdominal distension
  4. Abdominal pain upper
  5. Abscess soft tissue (soft tissue abscesses)
  6. Acute respiratory distress syndrome
  7. Asthenia (weakness)
  8. Cardiac failure
  9. Conjunctivitis (pink eye)
  10. Erythema (redness of the skin)

male:

  1. Acute hepatic failure
  2. Abdominal pain
  3. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  4. Asthenia (weakness)
  5. Abdominal distension
  6. Altered state of consciousness (altered state of mind)
  7. Anaemia (lack of blood)
  8. Cardiac failure congestive
  9. Corneal perforation (small hole in a cornea)
  10. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)

Gloperba side effects by age (0-1 to 60+) *:

0-1:

  1. Cardiac failure

2-9:

n/a

10-19:

  1. Abdominal pain
  2. Granulocytes abnormal

20-29:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Abdominal pain
  4. Abdominal pain upper
  5. Conjunctivitis (pink eye)

30-39:

  1. Abscess soft tissue (soft tissue abscesses)
  2. Acute hepatic failure
  3. Acute respiratory distress syndrome
  4. Asthenia (weakness)
  5. Corneal perforation (small hole in a cornea)
  6. Dysarthria (speech disorder)
  7. Erythema (redness of the skin)
  8. Abdominal pain
  9. Abdominal distension

40-49:

  1. Acute hepatic failure
  2. Anaemia (lack of blood)

50-59:

  1. Asthenia (weakness)

60+:

  1. Altered state of consciousness (altered state of mind)
  2. Asthenia (weakness)
  3. Cardiac failure congestive
  4. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
  5. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

* Approximation only. Some reports may have incomplete information.

Do you take Gloperba?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on colchicine (the active ingredients of Gloperba) and Gloperba (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Gloperba:

All Gloperba side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: